从微生物–肠–脑轴分析焦虑、抑郁及睡眠障碍与炎症性肠病关系的研究进展
Research Progress on the Relationship among Anxiety, Depression, Sleep Disorders and Inflammatory Bowel Disease from the Microbiome-Gut-Brain Axis
DOI: 10.12677/acm.2024.1441099, PDF,   
作者: 胡志敏:新疆医科大学研究生学院,新疆 乌鲁木齐;高 峰*:新疆维吾尔自治区人民医院消化科,新疆 乌鲁木齐
关键词: 微生物–肠–脑轴焦虑抑郁睡眠障碍炎症性肠病Microbiome-Gut-Brain Axis Anxiety Depression Sleep Disorders Inflammatory Bowel Disease
摘要: 炎症性肠病(IBD)是一种常见的慢性非特异性肠道炎症疾病,包括克罗恩病以及溃疡性结肠炎。随着我国人民生活习惯、饮食习惯的改变,近年来IBD在我国的发病率逐年升高,研究发现心理因素与IBD的疾病进展之间存在密切的关系,IBD患者焦虑、抑郁以及睡眠障碍的发生率较高。此外,肠屏障功能受损、肠道微生物群功能障碍以及肠道免疫功能异常等均在IBD发生发展过程中发挥着重要调控作用。本研究基于IBD患者心理因素以及微生物–肠–脑轴进行综述分析,从微生物–肠–脑轴分析焦虑、抑郁及睡眠障碍与炎症性肠病关系的研究进展。
Abstract: Inflammatory bowel disease (IBD) is a common chronic nonspecific intestinal inflammatory disease, including Crohn’s disease and ulcerative colitis. With the change of people’s living habits and eating habits in China, the incidence of IBD in China has increased year by year in recent years. Studies have found that there is a close relationship between psychological factors and the disease progress of IBD, and the incidence of anxiety, depression and sleep disorders in patients with IBD is high. In addition, intestinal barrier dysfunction, intestinal microflora dysfunction and intestinal immune dysfunction all play an important regulatory role in the occurrence and development of IBD. Based on the psychological factors of patients with IBD and the microbial-intestinal-brain axis, this study analyzes the relationship between anxiety, depression, sleep disorders and inflammatory bowel disease from the microbial-intestinal-brain axis.
文章引用:胡志敏, 高峰. 从微生物–肠–脑轴分析焦虑、抑郁及睡眠障碍与炎症性肠病关系的研究进展[J]. 临床医学进展, 2024, 14(4): 862-868. https://doi.org/10.12677/acm.2024.1441099

参考文献

[1] Fu, Q., Song, T., Ma, X., et al. (2022) Research Progress on the Relationship between Intestinal Microecology and Intestinal Bowel Disease. Animal Models and Experimental Medicine, 5, 297-310. [Google Scholar] [CrossRef] [PubMed]
[2] Xu, C., Gu, L., Hu, L., et al. (2023) FADS1-Arachidonic Acid Axis Enhances Arachidonicacid Metabolism by Altering Intestinal Microecology in Colorectal Cancer. Nature Communications, 14, Article 2042. [Google Scholar] [CrossRef] [PubMed]
[3] Li, Z., Lai, J., Zhang, P., et al. (2022) Multi-Omics Analyses of Serum Metabolome, Gut Microbiome and Brain Function Reveal Dysregulatedmicrobiota-Gut-Brain Axis in Bipolar Depression. Molecular Psychiatry, 27, 4123-4135. [Google Scholar] [CrossRef] [PubMed]
[4] Bisgaard, T.H., Allin, K.H., Keefer, L., et al. (2022) Depression and Anxiety in Inflammatory Bowel Disease: Epidemiology, Mechanisms and Treatment. Nature Reviews Gastroenterology & Hepatology, 19, 717-726. [Google Scholar] [CrossRef] [PubMed]
[5] Agrawal, M., Allin, K.H., Petralia, F., et al. (2022) Multiomics to Elucidate Inflammatory Bowel Disease Risk Factors and Pathways. Nature Reviews Gastroenterology & Hepatology, 19, 399-409. [Google Scholar] [CrossRef] [PubMed]
[6] 盛天骄, 闫思蒙, 兰威儒, 等. 肠道微生物对炎症性肠病影响研究进展[J]. 临床军医杂志, 2023, 51(9): 904-907.
[7] 张会园. IBD患者心理社会适应与病耻感、社会支持、应对方式的关系研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2023.
[8] Seyedian, S.S., Nokhostin, F. and Malamir, M.D. (2019) A Review of the Diagnosis, Prevention, and Treatment Methods of Inflammatory Bowel Disease. Journal of Medicine and Life, 12, 113-122. [Google Scholar] [CrossRef] [PubMed]
[9] He, J., Jin, Y., He, C., et al. (2024) DangguiShaoyao San: Comprehensive Modulation of the Microbiota-Gut-Brain Axis for Attenuating Alzheimer’s Disease-Related Pathology. Frontiers in Pharmacology, 12, Article 1338804. [Google Scholar] [CrossRef] [PubMed]
[10] Yang, Y.L., Huang, Y.H., Wang, F.S., et al. (2023) MicroRNA-29a Compromises Hepatic Adiposis and Gut Dysbiosis in High Fat Diet-Fed Mice via Downregulating Inflammation. Molecular Nutrition & Food Research, 67, e2200348. [Google Scholar] [CrossRef] [PubMed]
[11] Bayer, F., Ascher, S., Kiouptsi, K., et al. (2021) Colonization with Altered Schaedler Flora Impacts Leukocyte Adhesion in Mesenteric Ischemia-Reperfusion Injury. Microorganisms, 9, Article 1601. [Google Scholar] [CrossRef] [PubMed]
[12] 王晓钰, 蒋升瑶, 蔺智兵, 等. 基于糖尿病-肿瘤小鼠模型研究糖尿病对结直肠癌/乳腺癌进展及肠道菌群的影响[J]. 实验动物与比较医学, 2021, 41(6): 469-479.
[13] You, M., Li, S., Yan, S., et al. (2023) Exposure to Nonylphenol in Early Life Causes Behavioural Deficits Related with Autism Spectrum Disorders in Rats. Environment International, 180, Article 108228. [Google Scholar] [CrossRef] [PubMed]
[14] Hantsoo, L. and Payne, J.L. (2023) Towards Understanding the Biology of Premenstrual Dysphoric Disorder: From Genes to GABA. Neuroscience & Biobehavioral Reviews, 149, Article 105168. [Google Scholar] [CrossRef] [PubMed]
[15] Agus, A., Planchais, J. and Sokol, H. (2018) Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe, 23, 716-724. [Google Scholar] [CrossRef] [PubMed]
[16] Chen, L.M., Bao, C.H., Wu, Y., et al. (2021) Tryptophan-Kynurenine Metabolism: A Link between the Gut and Brain for Depression in Inflammatory Bowel Disease. Journal of Neuroinflammation, 18, Article No. 135. [Google Scholar] [CrossRef] [PubMed]
[17] Na, Y.R., Stakenborg, M., Seok, S.H., et al. (2019) Macrophages in Intestinal Inflammation and Resolution: A Potential Therapeutic Target in IBD. Nature Reviews Gastroenterology & Hepatology, 16, 531-543. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, X., Han, J., Xu, Y., et al. (2022) TSPO Deficiency Exacerbates GSDMD-Mediated Macrophage Pyroptosis in Inflammatory Bowel Disease. Cells, 11, Article 856. [Google Scholar] [CrossRef] [PubMed]
[19] Seifi, M., Rodaway, S., Rudolph, U., et al. (2018) GABAA Receptor Subtypes Regulate Stress-Induced Colon Inflammation in Mice. Gastroenterology, 155, 852-864. [Google Scholar] [CrossRef] [PubMed]
[20] Ling, X., Peng, S., Zhong, J., et al. (2022) Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats with Irritable Bowel Syndrome. Frontiers in Pharmacology, 13, Article 778032. [Google Scholar] [CrossRef] [PubMed]
[21] Qi, Y., Wang, X., Zhang, Y., et al. (2023) Walnut-Derived Peptide Improves Cognitive Impairment in Colitis Mice Induced by Dextran Sodium Sulfate via the Microbiota-Gut-Brain Axis (MGBA). Journal of Agricultural and Food Chemistry, 71, 19501-19515. [Google Scholar] [CrossRef] [PubMed]
[22] Everett, B.A., Tran, P. and Prindle, A. (2022) Toward Manipulating Serotonin Signaling via the Microbiota-Gut-Brain Axis. Current Opinion in Biotechnology, 78, Article 102826. [Google Scholar] [CrossRef] [PubMed]
[23] Helene, M.S, Yvonne, C., Michael, S., et al. (2016) Prebiotic Administration Normalizes Lipopolysaccharide (LPS)-Induced Anxiety and Cortical 5-HT2A Receptor and IL1-β Levels in Male Mice. Brain, Behavior, and Immunity, 52, 120-131. [Google Scholar] [CrossRef] [PubMed]
[24] Frankiensztajn, L.M., Elliott, E. and Koren, O. (2020) The Microbiota and the Hypothalamus-Pituitary-Adrenocortical (HPA) Axis, Implications for Anxiety and Stress Disorders. Current Opinion in Neurobiology, 62, 76-82. [Google Scholar] [CrossRef] [PubMed]
[25] Choi, K.W., Kim, Y.-K. and Jeon, H. (2020) Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment. In: Kim, Y.K., Ed., Anxiety Disorders. Advances in Experimental Medicine and Biology, Vol. 1191, Springer, Singapore, 219-235. [Google Scholar] [CrossRef] [PubMed]
[26] Black, J., Sweeney, L., Yuan, Y., et al. (2022) Systematic Review: The Role of Psychological Stress in Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics, 56, 1235-1249. [Google Scholar] [CrossRef] [PubMed]
[27] Leone, D., Menichetti, J., Fiorino, G., et al. (2014) State of the Art: Psychotherapeutic Interventions Targeting the Psychological Factors Involved in IBD. Current Drug Targets, 15, 1020-1029. [Google Scholar] [CrossRef] [PubMed]
[28] Sousa, J.F.M., Paghdar, S., Khan, T.M., et al. (2022) Stress and Inflammatory Bowel Disease: Clear Mind, Happy Colon. Cureus, 14, e25006.
[29] Rozich, J.J., Holmer, A. and Singh, S. (2020) Effect of Lifestyle Factors on Outcomes in Patients with Inflammatory Bowel Diseases. The American Journal of Gastroenterology, 115, 832-840. [Google Scholar] [CrossRef] [PubMed]
[30] Brooks, A.J., Rowse, G., Ryder, A., et al. (2016) Systematic Review: Psychological Morbidity in Young People with Inflammatory Bowel Disease—Risk Factors and Impacts. Alimentary Pharmacology & Therapeutics, 44, 3-15. [Google Scholar] [CrossRef] [PubMed]
[31] Gracie, D.J., Hamlin, P.J. and Ford, A.C. (2019) The Influence of the Brain-Gut Axis in Inflammatory Bowel Disease and Possible Implications for Treatment. The Lancet Gastroenterology & Hepatology, 4, 632-642. [Google Scholar] [CrossRef
[32] Cao, Q., Huang, Y.-H., Jiang, M., et al. (2019) The Prevalence and Risk Factors of Psychological Disorders, Malnutrition and Quality of Life in IBD Patients. Scandinavian Journal of Gastroenterology, 54, 1458-1466. [Google Scholar] [CrossRef] [PubMed]
[33] Triantafillidis, J.K., Merikas, E. and Gikas, A. (2013) Psychological Factors and Stress in Inflammatory Bowel Disease. Expert Review of Gastroenterology & Hepatology, 7, 225-238. [Google Scholar] [CrossRef] [PubMed]
[34] Morys, J.M., Kaczówka, A. and Jeżewska, M. (2016) Assessment of Selected Psychological Factors in Patients with Inflammatory Bowel Disease. Przegląd Gastroenterologiczny, 11, 47-53. [Google Scholar] [CrossRef] [PubMed]
[35] Menichetti, J., Fiorino, G. and Vegni, E. (2018) Personalizing Psychological Treatment along the IBD Journey: From Diagnosis to Surgery. Current Drug Targets, 19, 722-728. [Google Scholar] [CrossRef] [PubMed]
[36] Dasharathy, S.S., Long, M.D., Lackner, J.M., et al. (2023) Psychological Factors Associated with Adherence to Oral Treatment in Ulcerative Colitis. Inflammatory Bowel Diseases, 29, 97-102. [Google Scholar] [CrossRef] [PubMed]
[37] Martyniak, A., Medyńska-Przęczek, A., Wędrychowicz, A., et al. (2021) Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules, 11, Article 1903. [Google Scholar] [CrossRef] [PubMed]
[38] Zhou, J., Li, M., Chen, Q., et al. (2022) Programmable Probiotics Modulate Inflammation and Gut Microbiota for Inflammatory Bowel Disease Treatment after Effective Oral Delivery. Nature Communications, 13, Article 3432. [Google Scholar] [CrossRef] [PubMed]
[39] Lavelle, A. and Sokol, H. (2020) Gut Microbiota-Derived Metabolites as Key Actors in Inflammatory Bowel Disease. Nature Reviews Gastroenterology & Hepatology, 17, 223-237. [Google Scholar] [CrossRef] [PubMed]
[40] Tarasiuk, A. and Eibl, G. (2020) Nutritional Support and Probiotics as a Potential Treatment of IBD. Current Drug Targets, 21, 1417-1427. [Google Scholar] [CrossRef] [PubMed]
[41] 张朝柱, 何明霞, 王清, 等. 英夫利西单抗联合复合益生菌对炎症性肠病患者肠黏膜屏障、炎症因子、细胞免疫功能及骨代谢指标的影响[J]. 现代生物医学进展, 2021, 21(20): 3954-3958.
[42] Shen, Q., Huang, Z., Yao, J., et al. (2021) Extracellular Vesicles-Mediated Interaction within Intestinal Microenvironment in Inflammatory Bowel Disease. Journal of Advanced Research, 37, 221-233. [Google Scholar] [CrossRef] [PubMed]
[43] Zhang, W., Zou, G., Li, B., et al. (2020) Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation. Journal of Microbiolog and Biotechnology, 30, 1132-1141. [Google Scholar] [CrossRef] [PubMed]
[44] Khan, I., Ullah, N., Zha, L., et al. (2019) Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens, 8, Article 126. [Google Scholar] [CrossRef] [PubMed]
[45] Wu, Z., Huang, S., Li, T., et al. (2021) Gut Microbiota from Green Tea Polyphenol-Dosed Mice Improves Intestinal Epithelial Homeostasis and Ameliorates Experimental Colitis. Microbiome, 9, Article No. 184. [Google Scholar] [CrossRef] [PubMed]
[46] Wu, J., Wei, Z., Cheng, P., et al. (2020) Rhein Modulates Host Purine Metabolism in Intestine through Gut Microbiota and Ameliorates Experimental Colitis. Theranostics, 10, 10665-10679. [Google Scholar] [CrossRef] [PubMed]